Showing 1351-1360 of 2166 results for "".
Harrow Adds Biosimilars to US Portfolio
https://modernod.com/podcasts/eyewire-news-the-podcast/harrow-adds-biosimilars-to-us-portfolio/37094/Harrow enters a deal to expand it biosimilar pharma portfolio; the first gene-agnostic therapy to restore vision in RP patients advances; and Aldeyra provides an update on its dry eye drug candidate reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoicesFirst Myopia Drug Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/first-myopia-drug-approved-in-europe/37088/The first pharmaceutical treatment for myopia is approved in Europe; the FDA sets a target action date for a first-of-its-kind presbyopia drop; and John Berdahl, MD, discusses the reimbursement landscape in ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoicesA Two-Pronged Approach to Keratoconus Management
https://modernod.com/topics/contact-lenses/a-two-pronged-approach-to-keratoconus-management/38963/Post-crosslinking, patients may further benefit from eyeglasses or contact lenses.Making the Most of OCT Imaging
https://modernod.com/mod-issues/supplements-inserts/making-the-most-of-oct-imaging/38618/The utility of fundus evaluation in the front-line optometric clinic.Tactics for Effective Communication With Patients
https://modernod.com/topics/business/tactics-for-effective-communicationwith-patients/37948/Fine-tuning your communication skills can lead to better outcomes through increased compliance.Do Your Patients Take Supplements?
https://modernod.com/articles/significant-findings/do-your-patients-take-supplements/37840/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all curatOnboard Like You Mean It
https://modernod.com/topics/business/onboard-like-you-mean-it/48732/Keep these guidelines in mind when adding a new member to your team to make the process as useful as possible.When 20/Happy Falls Short
https://modernod.com/topics/ocular-surface/when-20happy-falls-short/39014/A thoughtful approach to managing post-cataract complaints.New MIGS Approach for Glaucoma Patients
https://modernod.com/articles/significant-findings/new-migs-approach-for-glaucoma-patients/39852/Significant Findings is MOD's weekly email newsletter for progressive-minded, full scope optometrists. Delivered to your inbox every Monday, Significant Findings offers fresh insights on the latest industry news, life anecdotes, current events related to the practice of optometry, and more—all cuCorneal Endothelial Cell Therapy
https://modernod.com/resources/visionary-breakthroughs/corneal-endothelial-cell-therapy-1/39821/An injectable cell therapy poised to rewrite the transplant playbook.